New approaches to filling the gap in tuberculosis drug discovery
2007

New Approaches to Tuberculosis Drug Discovery

publication Evidence: low

Author Information

Author(s): Martina Casenghi, Stewart T. Cole, Carl F. Nathan

Primary Institution: Médecins Sans Frontières

Hypothesis

How can we improve drug discovery for tuberculosis given the current challenges?

Conclusion

Despite the existence of a tuberculosis drug pipeline, there are still too few candidates to effectively combat the disease.

Supporting Evidence

  • There is a tuberculosis drug pipeline for the first time in decades.
  • Only three new drugs for tuberculosis were developed between 1975 and 2004.
  • Funding for tuberculosis research is alarmingly inadequate compared to other diseases.

Takeaway

Scientists are trying to find new medicines for tuberculosis, but there aren't enough options available to help people who are sick.

Limitations

Current funding for tuberculosis research is inadequate, and there is a lack of access to necessary expertise and resources.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0040293

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication